“Molecular Docking Study, and In Vitro Evaluation of Antitumor Activity of Some New Isoxazoline and Pyrazoline Derivatives of Nabumetone Against Breast Cancer Cell Line (MCF-7)”. Al Mustansiriyah Journal of Pharmaceutical Sciences, vol. 22, no. 3, Oct. 2022, pp. 24-34, https://doi.org/10.32947/ajps.v22i3.886.